Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-10-091152
Filing Date
2010-10-04
Accepted
2010-10-04 16:46:35
Documents
4
Period of Report
2010-11-07
Effectiveness Date
2010-10-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A y04015def14a.htm DEF 14A 416860
2 GRAPHIC y04015y0401500.gif GRAPHIC 1558
3 GRAPHIC y04015y0401501.gif GRAPHIC 2730
4 GRAPHIC y04015y0401502.gif GRAPHIC 2623
  Complete submission text file 0000950123-10-091152.txt   428533
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33357 | Film No.: 101106288
SIC: 2836 Biological Products, (No Diagnostic Substances)